Antihemophilic Factor (Recombinant) (Advate) and Daclatasvir Dihydrochloride
Determining the interaction of Antihemophilic Factor (Recombinant) (Advate) and Daclatasvir Dihydrochloride and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: antihemophilic factor
Brand name: Hemofil-M, Koate-DVI, Monoclate-P, Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Jivi, Obizur
Synonyms: Antihemophilic factor (human), Antihemophilic Factor (Human)
Generic Name: daclatasvir
Brand name: Daklinza
Synonyms: Daclatasvir
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Antihemophilic Factor (Recombinant) (Advate)-Daclizumab
- Antihemophilic Factor (Recombinant) (Advate)-Daclizumab Subcutaneous
- Antihemophilic Factor (Recombinant) (Advate)-Dacogen
- Antihemophilic Factor (Recombinant) (Advate)-Dacomitinib
- Antihemophilic Factor (Recombinant) (Advate)-Dactinomycin
- Antihemophilic Factor (Recombinant) (Advate)-Dactinomycin Injection
- Daclatasvir Dihydrochloride-Antihemophilic Factor (Recombinant) (Afstyla)
- Daclatasvir Dihydrochloride-Antihemophilic Factor (Recombinant) (Helixate FS and Kogenate FS)
- Daclatasvir Dihydrochloride-Antihemophilic Factor (Recombinant) (Kovaltry and Novoeight)
- Daclatasvir Dihydrochloride-Antihemophilic Factor (Recombinant) (Nuwiq)
- Daclatasvir Dihydrochloride-Antihemophilic Factor (Recombinant) (Recombinate)
- Daclatasvir Dihydrochloride-Antihemophilic Factor (Recombinant) (Xyntha)